Hande KÖKSAL, Naim KADOGLOU, Ayça EMSEN, Hülya UÇARYILMAZ, Hasibe ARTAÇ

The alteration of lymphocyte subsets in idiopathic granulomatous mastitis

Background and aim: This study analyzed peripheral blood lymphocyte subsets to determine their role in the etiopathogenesis of IGM. Materials and methods: This study includes 51 pathologically proven IGM patients (active disease: 26 and in remission: 25) and 28 healthy volunteers. The analyses of lymphocyte subsets were performed by flow cytometric immunophenotyping. Results: The percentage of T helper lymphocyte of all IGM patients were lower than control groups (p = 0.001). Absolute cytotoxic T lymphocyte count (p = 0.03), both percentage (p = 0.035) and absolute count (p = 0.002) of the natural killer cells, and both percentage (p = 0.038) and absolute count (p = 0.008) of natural killer T cells, were higher than the control group. The T helper lymphocyte percentage of the patients with active disease was lower than the control group (p = 0.0003). The absolute cytotoxic T lymphocyte (p = 0.029) and natural killer T cells (p = 0.012) of the patients with active disease were higher than the control group. Conclusion: Idiopathic granulomatous mastitis is defined as a localized form of granulomatous disorders. However, the observed changes in T cells, NK, and NKT cells suggest that there is systemic immune dysregulation in patients with IGM.Key words: Idiopathic granulomatous mastitis, lymphocyte subsets, autoimmunity, etiopathogenesis

PDF

___

1. Altintoprak F, Kivilcim T, Ozkan OV. Aetiology of idiopathic granulomatous mastitis. World Journal of Clinical Cases 2014; 2 (12): 852-858. doi:10.12998/wjcc.v2.i12.852
2. Benson JR, Dumitru D. Idiopathic granulomatous mastitis: presentation, investigation and management. Future Oncology 2016; 12 (11): 1381-1394. doi:10.2217/fon-2015-0038
3. Altintoprak F, Karakece E, Kivilcim T, Dikicier E, Cakmak G et al. Idiopathic granulomatous mastitis: an autoimmune disease? The Scientific World Journal 2013; 148727. doi: 10.1155/2013/148727
4. Sheybani F, Naderi HR, Gharib M, Sarvghad M, Mirfeizi Z. Idiopathic granulomatous mastitis: long-discussed but yetto-be-known. Autoimmunity 2016; 49 (4): 236-239. doi: 10.3109/08916934.2016.1138221
5. Salesi M, Karimifar M, Salimi F, Mahzouni P. A case of granulomatous mastitis with erythema nodosum and arthritis. Rheumatology International 2011; 31 (8): 1093-1095. doi: 10.1007/s00296-009-1273-0
6. Binesh F, Shiryazdi M, Bagher Owlia M, Azimi S. Idiopathic granulomatous mastitis, erythema nodosum and bilateral ankle arthritis in an Iranian woman. BMJ Case Reports 2013; 2013: bcr2012007636. doi: 10.1136/bcr-2012-007636
7. Alungal J, Abdulla MC, Narayan R. Idiopathic granulomatous mastitis with erythema nodosum and polyarthritis. Reumatismo 2016; 68 (2): 97-99. doi:10.4081/reumatismo.2016.844
8. Zabetian S, Friedman BJ, McHargue C. A case of idiopathic granulomatous mastitis associated with erythema nodosum, arthritis, and reactive cough. JAAD Case Reports 2016; 2 (2): 125-127. doi: 10.1016/j.jdcr.2016.01.011
9. Akın M, Karabacak H, Esendağlı G, Yavuz A, Gültekin S et al. Coexistence of idiopathic granulomatous mastitis and erythemanodosum: successful treatment with corticosteroids. Turkish Journal of Medical Sciences 2017; 47 (5): 1590-1592. doi: 10.3906/sag-1611-100
10. Fruchter R, Castilla C, Ng E, Pomeranz MK, Femia AN. Erythema nodosum in association with idiopathic granulomatous mastitis: a case series and review of the literature. Journal of the European Academy of Dermatology and Venereology 2017; 31 (9): e391-e393. doi: 10.1111/ jdv.14194
11. Letourneux C, Diemunsch P, Korganow AS, Akladios CY, Bellocq JP et al. First report of granulomatous mastitis associated with Sjögren’s syndrome. World Journal of Surgical Oncology 2013; 11: 268. doi:10.1186/1477-7819-11-268
12. Erhan Y, Veral A, Kara E, Ozdemir N, Kapkac M et al. A clinicopthologic study of a rare clinical entity mimicking breast carcinoma: idiopathic granulomatous mastitis. The Breast 2000; 9 (1): 52-56. doi: 10.1054/brst.1999.0072
13. Chen L, Zhang XY, Wang YV, Zhao QF, Ding HY. Granulomatous lobular mastitis: a clinicopathological analysis of 300 cases. Zhonghua Bing Li Xue Za Zhi. 2019; 48 (3): 231-236 (in Chinese). doi: 10.3760/cma.j.is sn.0529-5807.2019.03.012
14. Koksal H. Human leukocyte antigens class I and II in patients with idiopathic granulomatous mastitis. American Journal of Surgery 2019; 218 (3): 605-608. doi: 10.1016/j. amjsurg.2019.01.038
15. Lee BW, Yap HK, Chew FT, Quah TC, Prabhakaran K et al. Age- and sex-related changes in lymphocyte subpopulations of healthy Asian subjects: from birth to adulthood. Cytometry 1996; 26 (1): 8-15. doi:10.1002/(SICI)1097- 0320(19960315)26:1<8::AID-CYTO2>3.0.CO;2-E
16. Kessler E, Wolloch Y. Granulomatous mastitis: a lesion clinically simulating carcinoma. American Journal of Clinical Pathology 1972; 58: 642-646. doi:10.1093/ajcp/58.6.642
17. Cohen C. Granulomatous mastitis. A review of 5 cases. South African Medical Journal 1977; 52 (1): 14-16.
18. Ozel L, Unal A, Unal E, Kara M, Erdoğdu E et al. Granulomatous mastitis: is it an autoimmune disease? Diagnostic and therapeutic dilemmas. Surgery Today 2012; 42 (8): 729-733. doi: 10.1007/s00595-011-0046-z
19. Koksal H. The clinical utility of autoantibodies in patients with idiopathic granulomatous mastitis. Journal of Investigative Surgery 2020; 1-5. doi: 10.1080/08941939.2020.1861666
20. Koksal H, Vatansev H, Artac H, Kadoglou N. The clinical value of interleukins-8, -10, and -17 in idiopathic granulomatous mastitis. Clinical Rheumatology 2020; 39 (5): 1671-1677. doi:10.1007/s10067-020-04925-8
21. Co DO, Hogan LH, Il-Kim S, Sandor M. T cell contributions to the different phases of granuloma formation. Immunology Letters 2004; 92 (1-2): 135-142. doi: 10.1016/j.imlet.2003.11.023
22. Mannering SI, Zhong J, Cheers C. T-cell activation, proliferation and apoptosis in primary Listeria monocytogenes infection. Immunology 2002; 106 (1): 87-95. doi: 10.1046/j.1365- 2567.2002.01408.x
23. Mannering SI, Cheers C. Interleukin-2 and loss of immunity in experimental Mycobacterium avium infection. Infection and Immunity 2002; 70 (1): 27-35. doi: 10.1128/iai.70.1.27-35.2002
24. Kobayashi T, Kawamura H, Kanda Y, Matsumoto H, Saito S et al. Natural killer T cells suppress zymosan A-mediated granuloma formation in the liver by modulating interferon-γ and interleukin-10. Immunology 2012; 136 (1): 86-95. doi: 10.1111/j.1365-2567.2012.03562.x